DOAC Cancer VTE — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — The high gastrointestinal bleeding risk
DOACs are effective for many cancer-associated thromboembolic events, but an actively bleeding luminal gastrointestinal tumour substantially changes the benefit–harm balance. LMWH may be preferred while bleeding risk is high. Renal function, platelet count, interactions, tumour site and patient preference all require review.
Reference: https://www.nice.org.uk/guidance/ng158